Non-alcoholic fatty liver disease (NAFLD) is considered the most common liver disease.
Dietary supplementation has become a promising strategy for managing NAFLD …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver-related
morbidity and mortality disease in the world. However, no effective pharmacological …

Aims In recent years, more and more people are suffering from lifestyle-related disease such
as nonalcoholic fatty liver disease (NAFLD) because of unhealthy diet and lack of physical …

Nonalcoholic fatty liver disease (NAFLD) is a kind of serious fat disorder that has become a
critical problem to human society. Therefore, finding drugs that are safe and effective has …

Nonalcoholic fatty liver disease (NAFLD) is characterized by high levels of nonesterified fatty
acids (NEFA), inflammation, and hepatic steatosis. Inflammation plays a crucial role in the …

Lipid metabolic disorders and oxidative stress in the liver are key steps in the progression of
nonalcoholic fatty liver disease (NAFLD), which is a major risk factor for the development of …

Insulin resistance, oxidative stress, hyperlipidemia, and inflammation play main roles in the
development of nonalcoholic fatty liver disease (NAFLD). Some studies have reported that …

Scope Green tea extract (GTE) reduces liver steatosis and inflammation during nonalcoholic
steatohepatitis (NASH). We hypothesized GTE would mitigate NASH in a nuclear factor …

Background and Purpose Naringenin, a flavonoid compound with strong anti‐inflammatory
activity, attenuated non‐alcoholic fatty liver disease (NAFLD) induced by a methionine …

The global incidence of nonalcoholic fatty liver disease (NAFLD) has been surging in recent
years, however, no drug is currently approved to treat this disease. Quercetin, a natural …